Opko Health Inc. (NASDAQ:OPK) Set To Participate In Illumina, Inc. (NASDAQ:ILMN)’s iHope Program On International Rare Disease Day

Biotech Stock News

Opko Health Inc. (NASDAQ:OPK) has today come forward to make the announcement about GeneDx decision to be a part of Illumina, Inc. (NASDAQ:ILMN)’s iHope Network on International Rare Disease Day. It is going to participate in the capacity of one of the founding members. The iHope Network comprises of a number of clinical laboratory partners who support children through research and exploration of the various possible mechanisms that target helping those diagnosed with rare diseases.

The iHope program looks forward to taking advantage of its leading technology to bring to a stop the suffering associated with the patients who need its services. GeneDx is an iHope Network partner and it is quite an important move that it has decided to give a donation of 10 whole-genome sequencing tests yearly. It is also going to share its variant information. This move is a real-time reflection of a commitment it has had over the years. GeneDx has done so much in facilitating data sharing which as a result has helped promote better patient care and research.

Ryan Taft, who happens to be the Senior Director of the Scientific Research Population and Medical Genomics Department of Illumina showed his excitement over GeneDx’s entry in the support of iHope Network. The top official is optimistic that the joint efforts at play will actually go a long way towards transforming lives of pediatric patients believed to have little access to resources and who at the same time happen to be in dire need for a quick diagnosis.

The National Institutes of Health (NIH) is where the two scientists that founded GeneDx came from. As a matter of fact this was done in 2000 and it targeted the provision of diagnostic sort of testing for persons with rare and ultra-rare complexities. At this point in time, GeneDx has expanded to become a worldwide industry leader in genomics. This was of course after its dedication in which families from over 55 countries were provided with free testing .They are such acts that impress a lot of viewers that watch the Biotech Stock News.

Jane Juusola, who happens to be the Director of the Clinical Genomics Program in GeneDx on behalf of the company showed her excitement over GeneDx privilege to be a part of the Illumina’s iHope Network. She spoke of the company’s dedication and commitment to help children suffering from the undiagnosed rare diseases. The other Top Biotech Stocks need to emulate this for a better tomorrow.


Please enter your comment!
Please enter your name here